WELL Health Technologies Corp. (WHTCF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
WELL Health Technologies Corp. (WHTCF) trades at $3.26 with AI Score 56/100 (Grade B). WELL Health Technologies Corp. is a Canadian-based digital health company operating in Canada, the United States, and internationally. Market cap: $833M, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 15, 2026Analyst Coverage for WHTCF: WHTCF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WHTCF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
WHTCF: 1/3 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
WELL Health Technologies Corp. (WHTCF) Healthcare & Pipeline Overview
WELL Health Technologies Corp. is a practitioner-focused digital health company providing omni-channel patient services and digital solutions like EMR and telehealth platforms across Canada, the US, and internationally. They differentiate themselves through a comprehensive suite of services and a focus on technological innovation within the healthcare sector, but operate with a negative profit margin.
What Is the Investment Thesis for WHTCF?
WELL Health Technologies Corp. presents a compelling investment case based on its comprehensive digital health ecosystem and expanding market presence. The company's focus on practitioner-focused technology and omni-channel patient services positions it to capitalize on the growing demand for telehealth and digital healthcare solutions. Key value drivers include the continued adoption of OSCAR Pro and other telehealth platforms, expansion of clinic networks, and strategic acquisitions to broaden service offerings. The company's beta of 1.28 suggests higher volatility than the market. However, the negative profit margin of -3.6% and a P/E ratio of -23.99 indicate potential challenges in achieving profitability. Success hinges on effective execution of growth strategies and navigating the competitive landscape.
Based on FMP financials and quantitative analysis
WHTCF Key Highlights
Market Cap of $833M reflects the company's current valuation in the digital health market.
- Gross Margin of 37.8% indicates the profitability of WELL Health's services before operating expenses.
- Operates 30 primary care and executive care clinics as of December 31, 2021, demonstrating a physical presence alongside digital offerings.
- Provides services through 49 locations across Ontario, indicating a significant regional footprint.
- Beta of 1.28 suggests higher volatility compared to the overall market.
Who Are WHTCF's Competitors?
WHTCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ARRJF Arjo AB (publ) | $2.91 | +0.00% | $793M | 43 |
| EXETF Extendicare Inc. | $22.83 | +0.00% | $2.16B | 54 |
| IDRSF Idorsia Ltd | $7.31 | +0.00% | $1.86B | 58 |
| LTGHF Life Healthcare Group Holdings Limited | $0.69 | +0.00% | $987M | 44 |
| LTGHY Life Healthcare Group Holdings Limited | $2.85 | -2.40% | $1.02B | 42 |
| TALK Talkspace, Inc. | $5.25 | +0.00% | $879M | 91 |
| RKAGY RHON-KLINIKUM AG Unsponsored ADR | $8.16 | +0.00% | $1.09B | 52 |
| USPH U.S. Physical Therapy, Inc. | $79.21 | +1.28% | $1.21B | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WHTCF's Key Strengths?
Comprehensive suite of digital health solutions.
- Established network of clinics and telehealth platforms.
- Proprietary technology, including the OSCAR Pro EMR platform.
- Experienced management team with a track record of acquisitions.
What Are WHTCF's Weaknesses?
Negative profit margin and high P/E ratio.
- Reliance on acquisitions for growth.
- Exposure to regulatory changes in the healthcare industry.
- Competition from larger and more established players.
What Could Drive WHTCF Stock Higher?
Continued expansion of telehealth services and increased adoption of virtual care platforms.
- Strategic acquisitions to broaden service offerings and expand geographic footprint.
- Increased adoption of the OSCAR Pro electronic medical records (EMR) platform.
- Potential partnerships with healthcare providers and technology companies.
- Development and launch of new digital health solutions.
What Are the Key Risks for WHTCF?
Financial-distress signal — its Altman Z-Score of 1.16 sits in the distress zone (elevated bankruptcy risk).
- Rich valuation — a P/E of 42.0 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Intense competition in the digital health market.
- Regulatory changes and healthcare reforms.
- Cybersecurity threats and data privacy concerns.
- Economic downturn and reduced healthcare spending.
- Negative profit margin and high P/E ratio.
What Are the Growth Opportunities for WHTCF?
- Expansion of Telehealth Services: WELL Health can capitalize on the increasing adoption of telehealth by expanding its virtual care platforms, such as Tia Health and VirtualClinic+. The global telehealth market is projected to reach $55.6 billion by 2027, presenting a significant growth opportunity. By enhancing its telehealth capabilities and expanding its reach, WELL Health can attract more patients and generate additional revenue streams. Timeline: Ongoing.
- Strategic Acquisitions: WELL Health can pursue strategic acquisitions to broaden its service offerings and expand its geographic footprint. Acquiring companies with complementary technologies or established clinic networks can accelerate growth and enhance market position. The company's past acquisitions, such as Adracare and Circle Medical, demonstrate its ability to integrate new businesses and leverage synergies. Timeline: Ongoing.
- Adoption of OSCAR Pro: Increased adoption of WELL Health's OSCAR Pro electronic medical records (EMR) platform can drive revenue growth and enhance customer loyalty. The EMR market is expected to grow as healthcare providers increasingly adopt digital solutions to improve efficiency and patient care. By offering a user-friendly and feature-rich EMR platform, WELL Health can attract more healthcare providers and generate recurring revenue. Timeline: Ongoing.
- Expansion into the US Market: WELL Health has the opportunity to expand its presence in the US market, which is the largest healthcare market in the world. By establishing partnerships with US healthcare providers or acquiring US-based digital health companies, WELL Health can gain access to a large and growing customer base. The US market offers significant growth potential for WELL Health's telehealth and digital health solutions. Timeline: Ongoing.
- Development of New Digital Health Solutions: WELL Health can invest in the development of new digital health solutions to address unmet needs in the healthcare market. This could include developing new telehealth platforms, remote patient monitoring devices, or artificial intelligence-powered diagnostic tools. By innovating and introducing new solutions, WELL Health can differentiate itself from competitors and attract new customers. Timeline: Ongoing.
What Are WHTCF's Competitive Advantages?
- Comprehensive Digital Health Ecosystem: WELL Health offers a wide range of services, creating a comprehensive ecosystem that attracts and retains customers.
- Proprietary Technology: The OSCAR Pro EMR platform and other telehealth platforms provide a technological advantage over competitors.
- Established Clinic Network: The company's network of clinics provides a physical presence and enhances brand recognition.
- Strategic Acquisitions: WELL Health's history of strategic acquisitions has expanded its service offerings and market reach.
What Does WHTCF Do?
WELL Health Technologies Corp., established in 2010 and headquartered in Vancouver, Canada, has evolved into a comprehensive digital health company. Originally known as Wellness Lifestyles Inc., the company rebranded in July 2018 to reflect its focus on technology-driven healthcare solutions. WELL Health operates in Canada, the United States, and internationally, providing a wide array of services. These include primary care, physiotherapy, occupational therapy, chiropractic, dietary, mental health counselling, and sleep-related services. The company also offers specialized care through gastroenterologists and diagnostic services related to cardiology, women's health, bone/muscle health, and cancer diagnostics. WELL Health's offerings extend to telehealth services, enabling remote patient care and consultations. A key component of their business is the operation of OSCAR Pro, an electronic medical records (EMR) platform, along with various telehealth platforms such as Tia Health, VirtualClinic+, VirtuelMed, Adracare, and Circle Medical. They also manage Apps.health, a digital health app marketplace, and Insig, which provides virtual care and digital patient engagement services. Additionally, WELL Health delivers billing and revenue cycle management solutions, including billing-as-a-service outsourcing, and cybersecurity protection for patient data. As of December 31, 2021, WELL Health operated 30 primary care and executive care clinics and provided services through 49 locations across Ontario.
What Products and Services Does WHTCF Offer?
- Provides primary care services through a network of clinics.
- Offers physiotherapy, occupational therapy, and chiropractic services.
- Delivers mental health counselling and sleep-related services.
- Provides specialized care through gastroenterologists.
- Offers diagnostic services related to cardiology, women's health, and bone/muscle health.
- Operates telehealth platforms for remote patient consultations.
- Develops and manages electronic medical records (EMR) systems.
- Provides billing and revenue cycle management solutions for healthcare providers.
How Does WHTCF Make Money?
- Generates revenue from patient services provided through its clinics and telehealth platforms.
- Earns revenue from subscription fees for its OSCAR Pro EMR platform.
- Receives fees for billing and revenue cycle management services.
- Monetizes its Apps.health digital health app marketplace through commissions and advertising.
What Industry Does WHTCF Operate In?
WELL Health Technologies Corp. operates within the rapidly evolving digital health industry, driven by increasing demand for telehealth, electronic medical records, and remote patient monitoring. The market is characterized by technological innovation, regulatory changes, and growing adoption of digital solutions by healthcare providers and patients. WELL Health competes with other digital health companies, traditional healthcare providers, and technology firms entering the healthcare space. The company's success depends on its ability to differentiate its offerings, navigate the competitive landscape, and capitalize on the growth opportunities in the digital health market.
Who Are WHTCF's Key Customers?
- Patients seeking primary care, specialized care, and telehealth services.
- Healthcare providers, including physicians, therapists, and specialists.
- Hospitals and clinics using WELL Health's EMR and billing solutions.
- Digital health app developers using the Apps.health marketplace.
Company Profile
WELL Health Technologies Corp. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Hamed Shahbazi. WHTCF has traded publicly since 2018.
Key Financial Metrics
Return on equity for WELL Health Technologies Corp. stands at 0.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.2%, showing how much profit it generates from its asset base. WHTCF trades at a trailing price-to-earnings ratio of 41.99, above the Healthcare sector average of ~23x. Its free cash flow yield is 7.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.80 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.3%, the inverse of the P/E and a quick read on earnings relative to price.
WHTCF Valuation & Market Position
With a $833M market cap, WELL Health Technologies Corp. sits in the small-cap segment of the market. Relative to its peer group, WHTCF's quantitative score of 56/100 is roughly in line with the peer average of 48/100.
Quarterly Financial Performance: WELL Health Technologies Corp.
Revenue for WELL Health Technologies Corp. came in at $400.4M during Q2 2026, a 8.5% improvement versus the preceding quarter. The company recorded a net loss of $10.9M, with diluted EPS of $-0.04. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, WHTCF averaged $0.01 in diluted EPS.
Financial Health
WELL Health Technologies Corp.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.16 places it in the distress zone, a signal of elevated financial risk.
Earnings Track Record
WELL Health Technologies Corp. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 11.8% below estimates on average.
Forward Outlook
Wall Street analysts project WELL Health Technologies Corp. revenue of about $1.61B for fiscal 2026, with EPS near $0.23. The estimate reflects 13 contributing analysts.
WHTCF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Comprehensive suite of digital health solutions.
- Established network of clinics and telehealth platforms.
- Proprietary technology, including the OSCAR Pro EMR platform.
- Experienced management team with a track record of acquisitions.
Bear Case
- Negative profit margin and high P/E ratio.
- Reliance on acquisitions for growth.
- Exposure to regulatory changes in the healthcare industry.
- Competition from larger and more established players.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $400M | -$11M | -$0.04 |
| Q1 2026 | $369M | -$12M | -$0.05 |
| Q4 2025 | $384M | $23M | $0.10 |
| Q3 2025 | $365M | $4M | $0.02 |
Based on FMP financials and quantitative analysis
WHTCF Latest News
No recent news available for WHTCF.
WHTCF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WHTCF.
Price Targets
Wall Street price target analysis for WHTCF.
WHTCF MoonshotScore
What does this score mean?
The MoonshotScore rates WHTCF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Hamed Shahbazi
CEO
Hamed Shahbazi is the CEO of WELL Health Technologies Corp. He has a background in technology and entrepreneurship, with experience in building and scaling businesses. Shahbazi has been instrumental in transforming WELL Health from a small clinic operator into a leading digital health company. His expertise lies in identifying and capitalizing on emerging trends in the healthcare industry, driving innovation, and executing strategic acquisitions. He is responsible for managing 1507 employees.
Track Record: Under Hamed Shahbazi's leadership, WELL Health Technologies Corp. has experienced significant growth and expansion. He has overseen the acquisition of several companies, including Adracare and Circle Medical, which have broadened WELL Health's service offerings and market reach. Shahbazi has also led the development and commercialization of the OSCAR Pro EMR platform, a key component of WELL Health's digital health ecosystem. He successfully rebranded the company in 2018.
WHTCF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that WELL Health Technologies Corp. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more challenging for investors to assess their financial health and performance. Investing in OTC Other stocks carries higher risks due to the potential for less transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investors should conduct thorough due diligence and carefully consider the risks before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Limited Financial Disclosure: The lack of comprehensive financial reporting can make it difficult to assess the company's financial health and performance.
- Lower Liquidity: Reduced trading volumes and wider bid-ask spreads can make it challenging to buy or sell shares at desired prices.
- Increased Price Volatility: The stock may be more susceptible to sudden price swings due to limited liquidity and market participation.
- Potential for Fraud or Manipulation: OTC markets are generally subject to less regulatory oversight, increasing the risk of fraudulent or manipulative activities.
- Going Concern Risk: Companies trading on the OTC Other tier may face a higher risk of financial distress or bankruptcy.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Research any legal or regulatory issues involving the company.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Established Business Operations: WELL Health Technologies Corp. has been in operation since 2010, indicating a degree of stability and experience.
- Comprehensive Service Offerings: The company provides a wide range of digital health solutions, suggesting a diversified business model.
- Strategic Acquisitions: WELL Health has a history of strategic acquisitions, demonstrating a proactive approach to growth and expansion.
- Experienced Management Team: The company is led by an experienced management team with a track record in the healthcare and technology industries.
- Presence in Multiple Markets: WELL Health operates in Canada, the United States, and internationally, indicating a global presence.
Common Questions About WHTCF (Healthcare)
What does the AI Score mean for WHTCF?
WHTCF holds an AI Score of 56/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. WELL Health Technologies Corp. is a Canadian-based digital health company operating in Canada, the United States, and internationally. They provide end-to-end omni-channel patient services …
What does WELL Health Technologies Corp. do?
WELL Health Technologies Corp. operates as a practitioner-focused digital health company, providing end-to-end omni-channel patient services. Their core business revolves around offering a suite of digital health solutions, including electronic medical records (EMR) systems like OSCAR Pro, telehealth platforms such as Tia Health and VirtualClinic+, and a digital health app marketplace called Apps.health.
What are the main risks for WHTCF?
WELL Health Technologies Corp. faces several risks inherent in the digital health industry. Intense competition from established players and new entrants could erode market share. Regulatory changes and healthcare reforms could impact the company's business model and profitability. Cybersecurity threats and data privacy concerns pose a significant risk to patient data and the company's reputation.
What are the key factors to evaluate for WHTCF?
WELL Health Technologies Corp. (WHTCF) holds an AI score of 56/100 (moderate). P/E: 42.0x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does WHTCF data refresh on this page?
WHTCF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven WHTCF's recent stock price performance?
WELL Health Technologies Corp. (WHTCF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive suite of digital health solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider WHTCF overvalued or undervalued right now?
WELL Health Technologies Corp. (WHTCF) trades at 42.0x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research WHTCF before investing?
Before investing in WELL Health Technologies Corp. (WHTCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding WHTCF to a portfolio?
Key strength of WELL Health Technologies Corp. (WHTCF): Comprehensive suite of digital health solutions. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis is pending and may provide further insights.